Filing Flows › Sanofi (SNY) › Q2 2026
Sanofi (SNY) Q2 2026 earnings results (second quarter 2026)
6-K filed Jul 30, 2026
Sanofi (SNY) reported revenue of $11.6B for the second quarter 2026 (Q2 2026), +16% from a year earlier and +10% from the quarter before. Operating margin was 9.0%, net earnings $377M (3.3% of revenue).
Sanofi, Q2 2026: revenue $11.6B (+16% year over year), operating margin 9.0%, net earnings $377M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.6B | +10% | +16% |
| Operating profit | $1.0B | -51% | — |
| Net earnings | $377M | -77% | — |
What changed
Revenue was €11.6B in Q2 2026, up 16% year over year and up 10% from the previous quarter.
Gross margin was 80.0%, up 2.6 points from a year earlier. Operating profit was €1.0B, a 9.0% margin (down 5.7 points year over year). Operating profit fell €0.43B even though revenue rose €1.6B versus a year earlier, so costs grew faster than sales. Operating expenses grew 31% against revenue growth of 16%. The fastest-growing cost line was Other operating costs (+38%). Net earnings were €0.34B, down 91% year over year.
Questions
What was Sanofi's revenue in the second quarter 2026?
Sanofi (SNY) reported revenue of $11.6B for the second quarter 2026 (Q2 2026), +16% from a year earlier and +10% from the quarter before.
Was Sanofi profitable in the second quarter 2026?
Operating profit was $1.0B (9.0% of revenue) and net earnings $377M.
Source: Sanofi 6-K on SEC EDGAR.